| Can a Protocol for Glycaemic Control Improve Type 2 Diabetes Outcomes After Gastric Bypass? | |
| | |
MedLine Citation:
|
PMID: 22052198 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Roux-en-Y gastric bypass surgery (RYGB) is an effective treatment for patients with type 2 diabetes (T2DM). Tight glycaemic control immediately after RYGB for T2DM may improve long-term glycaemic outcomes, but is also associated with a higher risk of hypoglycaemia. We designed a treatment algorithm to achieve optimal glycaemic control in patients with insulin-treated T2DM after RYGB and evaluated its feasibility, safety and efficacy. METHODS: Fifty patients following protocol-driven diabetes management were discharged on a fixed amount of metformin and glargine, with the insulin dose adjusted according to a standardised insulin sliding scale aiming for a fasting capillary glucose (FCG) of 5.5-6.9 mmol/L. Glycaemic outcome and remission of diabetes (defined as HbA1c < 6% and FCG levels < 5.6 mmol/L for at least 1 year without hypoglycaemic medication) were compared between patients who received protocol-driven treatment and a similar cohort of 49 patients following standard glycaemic management. RESULTS: At 1 year follow-up, the protocol-driven group showed a greater improvement in glycaemic control than the non-protocol-driven group (HbA1c -3.0 ± 0.2% vs. -1.2 ± 0.1%, P < 0.001; FCG levels -3.4 ± 0.2 vs. -2.0 ± 0.2 mmol/L, P = 0.02) and a higher remission rate from T2DM (50.0% vs. 6.1%, P < 0.001). No symptomatic hypoglycaemia was reported in either group. CONCLUSIONS: The protocol-driven management proved to be feasible, safe and effective in achieving targeted glycaemic control in T2DM after RYGB. The next step will be to scrutinise the efficacy of protocol-driven management in a randomised controlled clinical trial. |
| | |
Authors:
|
Wiebke K Fenske; Dimitri J Pournaras; Erlend T Aasheim; Alexander D Miras; Nicola Scopinaro; Samantha Scholtz; Carel W le Roux |
Related Documents
:
|
17351148 - A functional variant of the adipocyte glycerol channel aquaporin 7 gene is associated w... 10216518 - Insulin-like growth factor binding protein-1 as a predictor of glucose-stimulated hyper... 20028938 - Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes. 16400048 - Body mass index and waist circumference both contribute to differences in insulin-media... 11353688 - Renal fibrosis in diabetic and aortic-constricted hypertensive rats. 3289298 - Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused p... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-4 |
Journal Detail:
|
Title: Obesity surgery Volume: - ISSN: 1708-0428 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-4 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9106714 Medline TA: Obes Surg Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Investigative Medicine, Imperial Weight Centre, Imperial College London, London, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Gastroesophageal Reflux after Vertical Banded Gastroplasty is Alleviated by Conversion to Gastric By...
Next Document: Prevalence of Endocrine Disorders in Morbidly Obese Patients and the Effects of Bariatric Surgery on...